3
Announcements
Trials
Browse
Landscape
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Observational
1
Sponsor
Cancer Type
Classical hematology
1
CNS
1
Conditions
Leukemia
42
Precursor Cell Lymphoblastic Leukemia-Lymphoma
36
Lymphoma
32
Lymphoma, Follicular
26
Myelodysplastic Syndromes
24
Lymphoma, Large B-Cell, Diffuse
24
Lymphoma, Non-Hodgkin
23
Leukemia, Myeloid, Chronic-Phase
23
Burkitt Lymphoma
22
Leukemia, Myeloid, Accelerated Phase
21
Leukemia, Myeloid, Acute
20
Lymphoma, Large-Cell, Immunoblastic
19
Leukemia, Lymphocytic, Chronic, B-Cell
19
Lymphoma, Mantle-Cell
16
Lymphoma, B-Cell, Marginal Zone
16
Graft vs Host Disease
16
Multiple Myeloma
15
Dendritic Cell Sarcoma, Interdigitating
15
Blast Crisis
15
Myeloproliferative Disorders
14
Leukemia, Myelomonocytic, Chronic
14
Hodgkin Disease
14
Anemia, Refractory, with Excess of Blasts
13
Recurrence
11
Neoplasms, Plasma Cell
11
Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative
11
Congenital Abnormalities
11
Myelodysplastic-Myeloproliferative Diseases
10
Leukemia, Biphenotypic, Acute
10
Sezary Syndrome
8
Interventions
ziprasidone
1
Zolpidem
1
Warfarin
1
Vecuronium Bromide
1
Vancomycin
1
Tranexamic Acid
1
Tobramycin
1
Spironolactone
1
Sevelamer
1
Rocuronium
1
Piperacillin, Tazobactam Drug Combination
1
Pentobarbital
1
Oxycodone
1
Nifedipine
1
Nafcillin
1
Molindone
1
Methylprednisolone
1
Lurasidone Hydrochloride
1
Labetalol
1
Haloperidol
1
Fosfomycin
1
Clozapine
1
Ciprofloxacin
1
Cidofovir
1
Cefepime
1
Bosentan
1
Aminocaproic Acid
1
Amikacin
1
Alfentanil
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Completed
×
Heart Arrest
×
Methylprednisolone
×
Clear all
NCT01431326
2023-09-06
PTN_POPS
Duke University
Completed
3,520 enrolled